Do You Think It Is A Good Idea To Invest In Seagen Inc. (SGEN)?

The stock of Seagen Inc. (NASDAQ:SGEN) increased by $0.79 on Tuesday to at $207.05, up 0.38 percent. The last five days have seen an average of 1,438,087 shares of common stock traded. 21 times new highs were reached in the current year, with a gain of $78.54. The average number of shares traded over the last 20 days was 949,177, while the average volume over the last 50 days totaled 1,043,249.

SGEN stock appreciated 7.96% since last month. On 08/01/23, the company’s shares reached a one-month low of $191.62. The stock touched a high of $209.39 on 08/28/23, after rallying from a low of $116.08 in 52 weeks. The price of SGEN stock has risen by 61.12% or $78.54 this year, reaching a new high 21 times. Still, the stock price is down -1.12% from the 52-week high.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Insider Transactions

SGEN stock investors should be aware that Seagen Inc. (SGEN) stock had its last reported insider trading activity 57 days ago on Jul 03. On Jul 03, EVP, Commercial U.S. ROMP CHARLES R sold 708 shares at $192.46 each. This transaction resulted in the insider making $136,262. On Jun 07, HIMES VAUGHN B sold 16,215 shares at a price of US$195.29. After the transaction, the insider now owns 43,837 shares. EVP, Commercial U.S. ROMP CHARLES R had earlier sold 349 shares on May 16 for $189.86 a share. The transaction was completed for $66,261.

Valuation Metrics

Beta for the stock is 0.47. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 17.79, the price-to-book (PB) ratio of 14.83.

Financial Health

For the three months ended June 29, Seagen Inc.’s quick ratio was 2.70, while its current ratio was 3.30, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 76.50% percent. Seagen Inc.’s EBITDA margin for the year ended June 29 was -27.05%, whereas its operating margin stood at -34.80% for the same period. Based on annual data, it had gross profit of $1.55 billion and revenue of $1.96 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SGEN’s return on assets (ROA) during the last 12 months has been -20.20%. There was a -22.10% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -26.50%.

Earnings Surprise

According to Seagen Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $603.83 million, while revenues rose by 17.61% to $519.72 million. It was predicted that Seagen Inc.’s quarterly earnings would be -$1.13, but it ended up being -$0.81, beating the consensus by -39.50%. EBITDA was -$210.92 million for the quarter. At the end of Seagen Inc.’s most recent quarter ended June 29, its liabilities totaled 876.32 million, while its total debt was $111.38 million. Equity owned by shareholders amounts to $187.7 million.

Technical Picture

Here’s a quick look at Seagen Inc.’s (SGEN) price momentum from a technical perspective. As of 28 August, the RSI 9-day stood at 90.61%, suggesting the stock is Overbought, with a 13.76% historical volatility rate.

The stochastic %K and %D were 88.45% and 91.65% respectively, while the average true range (ATR) was 2.40. Based on the 14-day stochastic reading of 86.05%, the RSI (14) reading is 82.84%. On the 9-day MACD Oscillator, the stock is at 6.62, and the 14-day reading is at 7.85.

Analyst Ratings

In its most recent analyst report, Raymond James raised its rating on Seagen Inc. (NASDAQ: SGEN) to a Strong buy. Prior to this, analysts firm rated the stock as an Outperform. Analysts have assigned Seagen Inc. (SGEN) an Hold rating. SGEN is a stock that is recommended for selling by 0 brokerage firms, while 11 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 3 others recommend it as a buy.

What is SGEN’s price target for the next 12 months?

The current consensus forecast for the stock is between $228.00 and $229.00, with a median target price of $229.00. In analyzing these forecasts, the average price target given by analysts for Seagen Inc. (SGEN) is $228.88.

Most Popular

Related Posts